Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Genomic Health Inc. Stories

2011-02-24 07:00:00

REDWOOD CITY, Calif., Feb. 24, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Chief Operating Officer of Genomic Health, will provide a corporate update during the 2011 RBC Capital Markets' Healthcare Conference in New York on Wednesday, March 2, 2011 at 10:30 a.m. Eastern Time (ET). Additionally, Kim Popovits, President and Chief Executive Officer of Genomic Health, will be a featured speaker on a panel titled, "The Future of Molecular Testing" at...

2011-02-15 17:20:00

REDWOOD CITY, Calif., Feb. 15, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the presentation of two studies at the American Society of Clinical Oncology® (ASCO®)(1)) Genitourinary (GU) Cancer Symposium, including complete results from its prostate cancer gene identification study, which identified 295 genes strongly associated with clinical recurrence following radical prostatectomy with great consistency across multiple...

2011-02-08 15:00:00

REDWOOD CITY, Calif., Feb. 8, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended December 31, 2010. Total revenue for the year ended December 31, 2010 increased to $178.1 million, compared with $149.5 million in 2009, an increase of 19 percent. Product revenue was $174.9 million for the year ended December 31, 2010, compared with $146.6 million in 2009. Contract revenue comprised the balance of total...

2011-02-03 07:00:00

REDWOOD CITY, Calif., Feb. 3, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that its scientists successfully surveyed expression of the whole human transcriptome using next-generation DNA sequencing technology developed by Illumina, Inc., to test hypotheses for biomarker discovery in archived tumor and normal breast tissue samples. The study identified hundreds of coding and non-coding transcripts that are differentially expressed in tumor versus normal,...

2011-01-27 07:00:00

REDWOOD CITY, Calif., Jan. 27, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 8 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2010 financial results. The call and webcast will follow the release of the fourth quarter financial results after market close. Conference Call Details To access the live conference call on February 8 at 4:30 p.m. Eastern Time via...

2011-01-21 15:00:00

REDWOOD CITY, Calif., Jan. 21, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced presentation of three studies at the American Society of Clinical Oncology® (ASCO®) (1) Gastrointestinal (GI) Cancer Symposium, including one finding that high tumor grade was not a marker of higher recurrence risk in stage II colon cancer, suggesting that other markers, such as the Oncotype DX® Recurrence Score®...

2011-01-13 14:29:53

Laboratory study indicates need for more clinical research of mechanisms that influence the activity of oxaliplatin Genomic research could help doctors better target a drug widely used to treat colorectal cancer patients, according to a study by Genomic Health Inc. (Nasdaq: GHDX) and the Translational Genomics Research Institute (TGen). The drug, oxaliplatin, is widely used in colon cancer. It is used in early disease, following surgery in those cancers that are likely to recur. It is also...

2011-01-10 07:00:00

REDWOOD CITY, Calif., Jan. 10, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced it will accelerate its prostate cancer clinical development program with the goal of launching a test globally in 2013, previously planned for launch in 2014, in light of positive top-line results of a large gene identification study which were presented in December at the Society for Urologic Oncology (SUO) annual meeting. Genomic Health and its research partners from Cleveland...

2011-01-04 07:00:00

REDWOOD CITY, Calif., Jan. 4, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Executive Officer, will present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 10 at 3:30 p.m. Pacific Time. To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of Genomic Health's website at http://investor.genomichealth.com. Please...

2010-12-13 07:00:00

SAN ANTONIO, Dec. 13, 2010 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from seven new studies focusing on its multigene Oncotype DX(®) breast cancer test, which has helped guide treatment decisions in more than 175,000 breast cancer patients worldwide. The data, presented this past week at the 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), further confirm the clinical value associated with the Oncotype DX Recurrence...